Discussion
Diagnosis With Brief Discussion
- Diagnosis
- ANCA-associated granulomatous vasculitis (Wegener's granulomatosis)
- Radiologic Findings
- Chest CT shows a nodule and peribronchial consolidation with peripheral ground glass opacity. A nodule shows central low attenuation area at mediastinal window setting.
PNS CT shows sinusitis (Fig).
The patient underwent renal biopsy and pathologic result was ANCA (pauci-immune) associated focal necrotizing and crescentic glomerulonephritis. Also C-ANCA test was positive.
- Brief Review
- ANCA-associated granulomatous vasculitis (Wegener granulomatosis) is an uncommon necrotizing vasculitis affecting multiple organ systems. Classical manifestation is a clinical triad consisting of upper airway (almost 100%) and lower airway involvement (90%) and renal involvement (80%) although it may involve any part of the body. Patient symptom varies and depends on the organ system affected. Patients with pulmonary involvement often complain of cough with or without hemoptysis, dyspnea, fever, and chest pain. Elevation of serum cytoplasmic ANCA (c-ANCA) titers, usually directed toward proteinase 3 and myeloperoxidase, occurs in up to 90% of patients with active ANCA-associated granulomatous vasculitis.
Pulmonary nodules and masses are the most common CT findings of ANCA-associated granulomatous vasculitis and are seen in up to 70% of patients. Waxing and waning of the single or multiple pulmonary nodules and masses with random distribution are features of the disease. Central cavitation occurs in up to 50% of cases and most noncavitated nodules or masses show central low attenuation reflecting extensive central necrosis. CT halo sign (up to 15%) or reverse halo sign, radiating linear scarring, and pleural tags can be ancillary findings. Diffuse ground-glass opacity and consolidation (50%) may result from pulmonary hemorrhage or infection and bilateral perihilar and peribronchovascular distributions are the most common.
The tracheobronchial tree is the second most commonly affected area in the thorax (16-23% of cases) and subglottic portion of the trachea is most often common location. Segmental, focal, circumferential wall thickening involving the posterior membrane of the trachea is the typical radiologic findings. Pleural involvement (12-20% of the patient) causing pleural effusion and pleuritis and cardiac involvement as a form of pericarditis, coronary arteritis and myocardial ischemia owing to the vasculitis in small to medium-sized coronary artery could be also presented.
Without treatment, approximately 90% of patients with ANCA-associated granulomatous vasculitis die within 2 years of diagnosis. Aggressive immunosuppressive treatment with corticosteroid and cyclophosphamide is the best current therapy (remission rate; 87%). In April 2011, the FDA approved rituximab (a chimeric antibody to CD20 protein) in combination with steroids to treat patients with ANCA-associated granulomatous, but relapse is still common.
- References
- 1. Martinex F, Jonathan H, Digumarthy S, et al. Common and uncommon manifestations of wegener granulomatosis at chest CT: Radiologic-pathologic correlation Radiographics 2012;32:51-69
2. Ananthakrishnan L, Sharma N, Kanne J, et al. Wegener granulomatosis in the Chest; High resolution CT findings.AJR 2009;192:676-682
3. Lohrmann C, Uhl M, Kotter E, et al. Pulmonary manifestations of wegener granulomatosis: CT findings in 57 patients and a review of the literature EJR 2005;53:471-477
- Keywords
- Lung, Vasculitis, ANCA associated vasculitis,